← Leaderboards
Evgeny (eugene) G Izumchenko
Johns Hopkins University
$1,669,074
Attributed
$3,488,482
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $715.6K · FY2019–25$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,488,482 · 3
By mechanism
R01$2,586,482 · 1
R21$902,000 · 2
Top collaborators
- Daria A Gaykalova7 shared
- Le Shen2 shared
- Yuxuan Phoenix Miao1 shared
- Ari Rosenberg1 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- David L Thomas$44,227,388
- Deborah Persaud$30,632,571
- Elizabeth Marion Jaffee$29,780,612
- Joseph B. Margolick$86,818,342
- Gregory M Lucas$25,457,285
Others in their field
Other Emerging Leaders on “Malignant Neoplasms”
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
- Leonard Freedmand · Leidos Biomedical Research, Inc.$108,968,336
- Beverly Hayes · Leidos Biomedical Research, Inc.$98,336,166
- Martha Hering · Westat, Inc.$57,098,843
Research focus
Malignant NeoplasmsDesignTumorSamplingMolecularMalignant Mouth NeoplasmSpecimenCoupledTranscriptome SequencingSolidMediatingMalignant - DescriptorHead And Neck Squamous Cell CarcinomaApoptosisGenomicsHistologicEventDysplasiaBioinformaticsGenesCarcinogenesisBiologyEvolutionCell Proliferation
Grant awards (10)
Deciphering the mechanism of response to novel HPV-specific viral immune therapy in HPV associated head and neck cancer$451,000
R21 · FY2025 · DE · contact PI
PDCD10 as a novel driver for head and neck squamous cell carcinoma development$205,000
R21 · FY2024 · DE · contact PI
Delineating chromatin-related gene expression signatures as a function of HNSCC progression$325,949
R01 · FY2023 · DE
PDCD10 as a novel driver for head and neck squamous cell carcinoma development$246,000
R21 · FY2023 · DE · contact PI
Delineating chromatin-related gene expression signatures as a function of HNSCC progression$407,176
R01 · FY2022 · DE
Delineating chromatin-related gene expression signatures as a function of HNSCC progression$550,112
R01 · FY2021 · DE
Delineating chromatin-related gene expression signatures as a function of HNSCC progression$475,691
R01 · FY2020 · DE
Delineating chromatin-related gene expression signatures as a function of HNSCC progression$171,704
R01 · FY2020 · DE
Delineating chromatin-related gene expression signatures as a function of HNSCC progression$68,228
R01 · FY2020 · DE
Delineating chromatin-related gene expression signatures as a function of HNSCC progression$587,622
R01 · FY2019 · DE